A wireless hub includes a vehicle power connector that can draw power from a vehicle battery on a vehicle, a first wireless transmission circuit that can send or receive data with base stations in a long-range wireless network, a second wireless transmission circuit that can provide a short-range wireless network and to transfer data to and from electronic devices, and a network processor that can process data in the first wireless transmission circuit and the second wireless transmission circuit. The wireless hub has an antenna array for millimeter wave communications.

System and methods for maintaining a supply of health-related items are provided herein. The system includes, but is not limited to, a carrier configured to contain the health-related item. The system further includes, but is not limited to, a container having a compartment configured to store the carrier. The system includes, but is not limited to, an item presence sensor coupled to the container. The system includes, but is not limited to, a sensor tag coupled to carrier and configured to be communicatively coupled with the item presence sensor. The system includes, but is not limited to, one or more data processors configured to be communicatively coupled with the item presence sensor and configured to determine whether the health-related item is present within the container based upon proximity of the sensor tag to the item presence sensor.

A portable system is provided for measuring an analyte, such as acetone, in the breath or other bodily fluid of a user. The system includes a portable measurement device that analyzes fluid samples and generates corresponding measurements. The portable measurement device communicates with an application which runs on a smartphone or other mobile device of the user. The application tracks, and generates graphs of, the measurements, and may include various features for facilitating the analysis of the measurements.

An apparatus for producing information indicative of cardiac abnormality, for example Heart failure with preserved ejection fraction “HFpEF”, includes a signal interface for receiving a signal indicative of cardiac motion and a processing system coupled to the signal interface. The processing system is configured to extract, from the signal, temporal portions which belong to diastolic phases of a heart. The processing system is configured to set an output signal of the apparatus to express presence of cardiac abnormality based on a result of a comparison between the indicator quantity and a threshold value.

Systems, devices and methods are provided that allow for enhanced performance, power efficiency, interoperability, data security and user privacy for in vivo analyte monitoring systems that utilize wireless communications. The in vivo analyte monitoring systems can include a Bluetooth or Bluetooth Low Energy enabled handheld relay device for wirelessly relaying analyte data between a sensor unit device and one or more reader devices. The in vivo analyte monitoring systems can employ advertisement and encryption schemes for wirelessly transmitting data in a manner that allows for improved security, efficiency and privacy.

A bio-signal measurement apparatus may include a first substrate and a second substrate, an optical sensor mounted in the first substrate, a force sensor disposed on or below the first substrate, and a separation structure interposed between the first substrate and the second substrate so as to prevent transmission of a force between the first substrate and the second substrate. An upper surface of the first substrate and an upper surface of the second substrate may be provided at the same level.

A method comprises establishing communication between a therapy device implantable in a patient and a consumer electronic device operable by the patient. The method comprises controlling, by the consumer electronic device, a predetermined set of therapy device functions in response to patient inputs to the consumer electronic device. The method also comprises transmitting therapy data from the therapy device to the consumer electronic device. The method further comprises presenting therapy data on a display of the consumer electronic device.

An apparatus for estimating bio-information is provided. The apparatus for estimating bio-information may include: a pulse wave sensor configured to measure a pulse wave signal from an object; a force sensor configured to measure a force exerted by the object to the pulse wave sensor; and a processor configured to obtain a contact pressure based on the force and a reference contact area between the object and a contact surface, and estimate bio-information based on the contact pressure and the pulse wave signal.

An apparatus and method for employing the macro- and micro-structure of sleep and similar states of consciousness to optimize pain-treatment are disclosed wherein an objective biomarker of pain-related sleep disturbance guides pain treatment from a sleep perspective. Furthermore, this concept can be extended to states of reduced consciousness such as coma or sedation. Additionally, it could be applied on individuals who are non-communicative due to injury, disease, language issues and/or infancy.

Computer-implemented methods for providing interactive electronic treatment assistance for benign prostatic hyperplasia and advanced prostate cancer are disclosed. The methods can include automatically sending, by a disease and disorder treatment device, an electronic pathway sign-up link to a smart mobile device. The method can include sending a plurality of inquiries about the BPH condition and/or the advanced prostate cancer condition, to the smart mobile device. The method can include receiving a plurality of patient responses from the smart mobile device. The method can include processing and storing the plurality of patient responses. The method can include providing, by the disease and disorder treatment device, patient education about various treatment therapies for advanced prostate cancer. The method can include automatically monitoring a patient having the advanced prostate cancer condition during the various treatment therapies. The method can include intervening with the various treatment therapies using the smart mobile device.